A Win For Equillium, Inc.

Equillium, Inc. (EQ:NASDAQ) soared at $26.5, representing a gain of 730.7%. On Fri 10 Jul 20, EQ:NASDAQ hit a New 2-Week Intraday High of $3.43. The stock appeared on our News Catalysts scanner on Mon 13 Jul 20 at 07:50 AM in the 'MISCELLANEOUS' category. From Fri 26 Jun 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Equillium, Inc. (EQ:NASDAQ)

Equillium Inc is a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, which is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis.